Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 14 #1
CompanyEsperion Therapeutics, Inc.
Market Cap377.04MEPS (ttm)-2.08
P/E-EPS this Y90.90%
Forward P/E-EPS next Y17.60%
PEG-EPS past 5Y-29.50%
P/S-EPS next 5Y-
P/B6.39EPS Q/Q97.00%
Dividend-Sales Q/Q-
Insider Own-Inst Own81.30%
Insider Trans-Inst Trans0.57%
Short Float4.44%EarningsAug 12/a
Analyst Recom1.50Target Price30.00
Avg Volume41.53K52W Range10.90 - 24.94
02-Oct-14 10:05AMUPDATE: JMP Securities Reiterates On Esperion Therapeutics Inc Following Positive Trial Results Benzinga
02-Oct-14 10:00AMU.S. stocks look squishy after ECB, jobless claims at MarketWatch
02-Oct-14 09:17AMConstellation misses estimates; Tesla teases the 'D'; DirecTV and NFL extend pact Hot Stock Minute
02-Oct-14 09:10AMWhat We're Trading @optionmonster @petenajarian Yahoo Finance Blogs
02-Oct-14 08:07AMTesla climbs on product hint; Constellation falls at MarketWatch
02-Oct-14 07:57AMStocks slip; NFL deal boosts DirecTV; Elon Musk announces surprise Hot Stock Minute
01-Oct-14 06:03PMEsperion shares rally on cholesterol drug study at MarketWatch
01-Oct-14 05:08PMWhy Esperion Therapeutics (ESPR) Stock Is Soaring in After-Hours Trading Today at TheStreet
01-Oct-14 04:52PMEsperion shares rally on cholesterol drug study results at MarketWatch
01-Oct-14 04:16PM4:16 pm Esperion Therapeutics announces positive top-line Phase 2b results for ETC-1002, an investigational therapy for patients with hypercholesterolemia Briefing.com
Esperion Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of oral, low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. Its products include ETC-1002, an oral molecule therapy that is in Phase IIb clinical trials to treat lipid and carbohydrate metabolic pathways; ESP41091, which is in pre-clinical trials for type 2 diabetes and obesity treatment; and 4WF, a synthetic apoA-I therapy that is in pre-clinical trials for treating patients with acute coronary syndrome. The company is headquartered in Plymouth, Michigan.
CompanyStraight Path Communications Inc.
IndustryDiversified Communication Services
Market Cap191.04MEPS (ttm)-0.19
P/E-EPS this Y-173.80%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S119.40EPS next 5Y-
P/B13.16EPS Q/Q112.50%
Dividend-Sales Q/Q200.00%
Insider Own3.20%Inst Own26.70%
Insider Trans26.03%Inst Trans-15.95%
Short Float1.40%Earnings-
Analyst Recom-Target Price-
Avg Volume82.38K52W Range5.31 - 16.41
30-Sep-14 05:28PMSTRAIGHT PATH COMMUNICATIONS INC. Files SEC form 8-K, Other Events EDGAR Online
03-Sep-14 09:00AMStraight Path Communications Hires CTO to Lead the Charge to 5G Business Wire
26-Aug-14 11:07AMShares Of Straight Path Communications Surge Following 8-K Filing Benzinga
26-Aug-14 08:38AMSTRAIGHT PATH COMMUNICATIONS INC. Files SEC form 8-K, Other Events EDGAR Online
04-Aug-14 05:00PMSTRAIGHT PATH COMMUNICATIONS INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
21-Jun-14 01:04PMSTRAIGHT PATH COMMUNICATIONS INC. Financials EDGAR Online Financials
17-Jun-14 11:39AMWhy Straight Path Communications (STRP) Stock Is Higher Today at TheStreet
17-Jun-14 06:02AMSTRAIGHT PATH COMMUNICATIONS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem EDGAR Online
16-Jun-14 05:40PMStraight Path Communications Reports Results for Third Quarter Fiscal 2014 PR Newswire
16-Jun-14 01:01PMSTRAIGHT PATH COMMUNICATIONS INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Straight Path Communications Inc., through its subsidiaries, holds, leases, and markets fixed wireless spectrum licenses in the United States. Its licenses include approximately 814 licenses of 39 GHz and 133 licenses in the local multipoint distribution service (LMDS) band. The company provides point-to-point and point-to-multipoint wireless broadband digital telecommunications services to telecommunications providers and other companies. Its spectrum is primarily used to provide backhaul services for existing wireless Internet service providers, including providers that serve WiFi markets in venues, businesses, and outdoor public spaces; and for cellular mobile backhaul. The company also holds intellectual property primarily related to communications over the Internet, and the licensing and other businesses related to the intellectual property. It primarily owns 11 patents, which are related to various communications technologies, including patents facilitating the use of communications over the Internet; and the Droplet Portfolio of patents, as well as a non-sublicensable, non-exclusive right in source code for peer to peer calling applications. Straight Path Communications Inc. was incorporated in 2013 and is headquartered in Glen Allen, Virginia.
CompanyImmune Design Corp.
Market Cap305.33MEPS (ttm)-1.53
P/E-EPS this Y-47.10%
Forward P/E-EPS next Y15.60%
PEG-EPS past 5Y0.00%
P/S254.45EPS next 5Y5.00%
P/B-EPS Q/Q-105.30%
Dividend-Sales Q/Q83.30%
Insider Own16.80%Inst Own38.50%
Insider Trans-Inst Trans-
Short Float0.07%Earnings-
Analyst Recom1.00Target Price20.00
Avg Volume95.16K52W Range11.51 - 19.05
02-Oct-14 08:00AMImmune Design Added to Russell 2000(R) Index GlobeNewswire
08-Sep-14 04:58PMIMMUNE DESIGN CORP. Files SEC form 10-Q, Quarterly Report EDGAR Online
07-Aug-14 08:00AMSanofi Licenses Immune Design's GLAAS Platform to Explore Novel Approach to Treat Food Allergy GlobeNewswire
29-Jul-14 04:05PMIMMUNE DESIGN CORP. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial St EDGAR Online
29-Jul-14 04:00PMImmune Design Announces Closing of Initial Public Offering GlobeNewswire
25-Jul-14 04:12PMIMMUNE DESIGN CORP. Files SEC form 8-K, Financial Statements and Exhibits EDGAR Online
25-Jul-14 04:00PMIMDZ Announces Filing of New Lawsuit by Theravectys SA GlobeNewswire
24-Jul-14 07:00AMImmune Design Announces Pricing of Initial Public Offering GlobeNewswire
24-Jul-14 06:19AMImmune Design 5M share IPO priced at $12.00 at theflyonthewall.com
24-Jul-14 12:45AMIPO Preview: Immune Design at Seeking Alpha
Immune Design Corp., a clinical-stage immunotherapy company, focuses on the development of novel immune-based therapies based on its DCVex and GLAAS discovery platforms for cancer and other chronic conditions. Its product candidates in Phase I clinical trials comprise LV305, CMB305, and G305 for the treatment of solid tumor types, such as breast cancer, melanoma, non-small cell lung cancer, ovarian cancer, or sarcoma; and G100 for the treatment of patients with merkel cell carcinoma. The company was formerly known as VaccSys Inc. and changed its name to Immune Design Corp. in June, 2008. The company was founded in 2008 and is headquartered in Seattle, Washington.
Company1-800-Flowers.com Inc.
IndustrySpecialty Retail, Other
Market Cap488.65MEPS (ttm)0.22
P/E34.73EPS this Y-8.30%
Forward P/E20.11EPS next Y35.71%
PEG2.17EPS past 5Y17.60%
P/S0.65EPS next 5Y16.00%
P/B2.67EPS Q/Q400.00%
Dividend-Sales Q/Q8.30%
Insider Own0.90%Inst Own77.80%
Insider Trans-0.81%Inst Trans2.11%
Short Float3.73%EarningsOct 28/b
Analyst Recom1.50Target Price8.63
Avg Volume138.03K52W Range4.53 - 7.69
01-Oct-14 07:45PMTaking Stock: Jim McCann of 1-800-Flowers on Harry & David at Bloomberg
01-Oct-14 11:59AMWhy 1-800-FLOWERS.com (FLWS) Stock Is Gaining Today at TheStreet
30-Sep-14 05:32PM5:32 pm 1-800-FLOWERS completes acquisition of Harry & David Holdings; now sees FY15 revenue in excess of $1.1 bln; sees FY15 EPS of $0.45-0.50 Briefing.com
30-Sep-14 05:00PM1-800-FLOWERS.COM® Completes Its Acquisition of Harry & David Holdings, Inc., Creating a Leading Floral and Gourmet Gift Retailer with More than $1.1 Billion in Annual Sales Business Wire
19-Sep-14 01:04PM1 800 FLOWERS COM INC Financials EDGAR Online Financials
16-Sep-14 12:26PMI Heart FLORISTS Celebrates the Passion and Creativity of Local Florists Business Wire
12-Sep-14 03:59PMDow Falls Over 100 Points; Ulta Salon Shares Jump After Earnings Report Benzinga
12-Sep-14 02:02PMConversant Shares Rise On Acquisition News; Health Care REIT Drops Benzinga
12-Sep-14 01:38PM1 800 FLOWERS COM INC Files SEC form 10-K, Annual Report EDGAR Online
12-Sep-14 09:14AMCompany News for September 12, 2014 Zacks
1-800-FLOWERS.COM, Inc. operates a florist and gift shop in the United States. The company operates in three segments: Consumer Floral, Gourmet Food and Gift Baskets, and BloomNet Wire Service. It offers various products, such as fresh-cut flowers, floral and fruit arrangements and plants, gifts, popcorn, gourmet foods and gift baskets, cookies, chocolates, candies, wine, candles, balloons, and plush stuffed animals. The company provides gourmet gifts, such as popcorn and specialty treats from thepopcornfactory.com; cookies and baked gifts from cheryls.com; chocolates and confections from fanniemay.com and harrylondon.com; gift baskets and towers from 1-800-BASKETS.COM; carved fresh fruit arrangements from FruitBouquets.com; steaks and chops from stockyards.com; and invitations and personal stationery from FineStationery.com. It also offers creative party ideas, must-read articles, online invitations, and e-cards under the Celebrations brand from celebrations.com. As of June 29, 2014, the company operates one floral retail store in New York and eight floral retail stores in the Mid-West. In addition, it has 196 floral franchised stores located in the United States. The company was founded in 1976 and is headquartered in Carle Place, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GALLAGHER GERARD MGeneral Counsel and SVPDec 09Sale4.9818,58792,563256,089Dec 10 04:36 PM
GALLAGHER GERARD MGeneral Counsel and SVPDec 06Sale5.0118,09190,636274,676Dec 10 04:36 PM
TickerHNH [NASD]
CompanyHandy & Harman Ltd.
IndustryIndustrial Equipment & Components
Market Cap300.93MEPS (ttm)2.29
P/E12.18EPS this Y24.70%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-5.90%
P/S0.44EPS next 5Y-
P/B2.59EPS Q/Q10.50%
Dividend-Sales Q/Q7.40%
Insider Own0.40%Inst Own80.90%
Insider Trans-69.42%Inst Trans6.76%
Short Float1.58%EarningsJul 31
Analyst Recom-Target Price-
Avg Volume23.95K52W Range17.20 - 28.23
11-Sep-14 04:07PMHandy & Harman Ltd. Announces Final Results of Tender Offer PR Newswire
08-Sep-14 07:00AMHandy & Harman Ltd. Announces Preliminary Results of Tender Offer PR Newswire
02-Sep-14 06:00AMHANDY & HARMAN LTD. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definit EDGAR Online
19-Aug-14 08:55AMHandy & Harman Ltd. Announces Increase In Tender Offer Price PR Newswire
08-Aug-14 01:04PMHANDY & HARMAN LTD. Financials EDGAR Online Financials
06-Aug-14 09:35PMHandy & Harman Ltd. to Commence Tender Offer to Repurchase Up to $60 Million in Value of Shares of Its Common Stock PR Newswire
06-Aug-14 05:26PMHANDY & HARMAN LTD. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob EDGAR Online
31-Jul-14 04:32PMHANDY & HARMAN LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
31-Jul-14 04:26PMHandy & Harman Ltd. Reports Second Quarter Financial Results and Outlook for 2014 Business Wire
31-Jul-14 04:02PMHANDY & HARMAN LTD. Files SEC form 10-Q, Quarterly Report EDGAR Online
Handy & Harman Ltd. manufactures and sells engineered niche industrial products in the United States and internationally. Its Joining Materials segment fabricates precious metals and their alloys into brazing alloys, including gold, silver, palladium, copper, nickel, aluminum, and tin for use in electrical, appliance, transportation, construction, and general industrial industries. The company's Tubing segment provides seamless stainless steel tubing coils for petrochemical infrastructure and shipbuilding markets; small diameter coil tubing to the aerospace, defense, and semiconductor fabrication markets; and welded carbon steel tubing products for automotive, oil and gas, and heating, ventilation and cooling industries. Its Building Materials segment offers fasteners and fastening systems for the commercial low slope roofing industry; and engineered specialty fasteners for the building products industry. The company's Arlon Electronic Materials segment provides materials for the printed circuit board industry and silicone rubber-based insulation materials used in industrial, military/aerospace, consumer, and commercial markets, as well as supplies circuit substrate laminate materials and silicone rubber materials. Its Kasco Blades and Route Repair Services segment offers meat-room blade products, repair services, and resale products for the meat and deli departments of supermarkets, restaurants, meat and fish processing plants, and for distributors of electrical saws and cutting equipment; and wood cutting blade products for the pallet manufacturing, pallet recycler, and portable saw mill industries. The company sells its products and services through direct sales forces, distributors, and manufacturer's representatives to the construction, electronics, telecommunications, transportation, utility, medical, semiconductor, aerospace, aviation, military electronics, and food industries. Handy & Harman Ltd. was founded in 1852 and is based in White Plains, New York.
TickerSLI [AMEX]
CompanySL Industries Inc.
IndustryDiversified Electronics
Market Cap207.62MEPS (ttm)2.98
P/E16.83EPS this Y3.20%
Forward P/E-EPS next Y-
PEG-EPS past 5Y23.40%
P/S0.97EPS next 5Y-
P/B3.12EPS Q/Q151.90%
Dividend-Sales Q/Q13.90%
Insider Own1.60%Inst Own79.20%
Insider Trans29.27%Inst Trans1.11%
Short Float0.37%EarningsNov 04
Analyst Recom1.00Target Price-
Avg Volume21.15K52W Range20.48 - 50.44
03-Sep-14 08:15AMSL Power Solves Power Challenges for Next Generation Medical Devices With New 65 Watt AC/DC Power Supply Marketwired
15-Aug-14 07:29PMMario Gabelli Sells 3% of Holdings in SL Industries Gurufocus
08-Aug-14 01:04PMSL INDUSTRIES INC Financials EDGAR Online Financials
01-Aug-14 04:14PMSL Industries Announces 2014 Second Quarter Results Business Wire
01-Aug-14 04:06PMSL INDUSTRIES INC Files SEC form 10-Q, Quarterly Report EDGAR Online
28-May-14 08:15AMSL Power Solves Test & Measurement Power Challenges With New TU425 AC/DC Power Supply Family Marketwired
15-May-14 03:11PMSL INDUSTRIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of Matters to a Vote of EDGAR Online
05-May-14 01:45PMSL INDUSTRIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online
05-May-14 09:15AMSL Industries Announces 2014 First Quarter Results Business Wire
02-May-14 04:10PMSL INDUSTRIES INC Files SEC form 10-Q, Quarterly Report EDGAR Online
SL Industries, Inc., through its subsidiaries, designs, manufactures, and markets power electronics, motion control, power protection, power quality, and communication equipment primarily in the United States. It operates in four segments: SL Power Electronics Corp. (SLPE), High Power Group, SL Montevideo Technology, Inc. (SL-MTI), and RFL Electronics Inc. (RFL). The SLPE segment offers power conversion products under the SL Power Electronics, Condor, and Ault brands to the original equipment manufacturers (OEMs) of medical, industrial/instrumentation, military, and information technology equipment. The High Power Group segment provides custom power conditioning and distribution units for OEMs of medical imaging, medical treatment, military aerospace, semiconductor, solar, and advanced simulation systems. This segment also offers harmonic filters, three-phase AC reactors, DC link chokes, and motor protection filters, as well as designs and builds customer specific and custom products for special applications that are used in industrial plants, renewable energy facilities, and commercial buildings. This segment sells its products under the Teal and MTE brands. The SL-MTI segment designs and manufactures high power density precision motors, which are used in various applications, including military and commercial aerospace, oil and gas, medical, and industrial products. The RFL segment designs and manufactures communication and power protection products/systems that are used to protect electric utility transmission lines and apparatus; and products and systems used by rail and highway industries, as well as offers systems design, commissioning, training, customer service, and maintenance services for its products. The company was formerly known as SGL Industries, Inc. and changed its name to SL Industries, Inc. in September 1984. SL Industries, Inc. was founded in 1956 and is based in Mount Laurel, New Jersey.
CompanySagent Pharmaceuticals, Inc.
IndustryDrugs - Generic
Market Cap1.01BEPS (ttm)0.46
P/E68.78EPS this Y265.00%
Forward P/E51.11EPS next Y139.00%
PEG2.20EPS past 5Y19.10%
P/S3.81EPS next 5Y31.20%
P/B4.09EPS Q/Q-80.40%
Dividend-Sales Q/Q16.10%
Insider Own0.30%Inst Own73.80%
Insider Trans-57.22%Inst Trans4.24%
Short Float5.86%EarningsNov 04/b
Analyst Recom2.90Target Price28.00
Avg Volume192.03K52W Range17.49 - 31.86
02-Oct-14 08:00AMSAGENT PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisitio EDGAR Online
01-Oct-14 04:10PM4:10 pm Sagent Pharma announces acquisition of Omega Laboratories; expected to be immediately accretive to cash earnings Briefing.com
01-Oct-14 04:10PMSagent Pharmaceuticals Announces Acquisition of Omega Laboratories GlobeNewswire
29-Sep-14 12:09PMAkorn Upgraded On Strong Generic Drug Trends at Investor's Business Daily
26-Sep-14 01:41PMSagent Pharmaceuticals Announces the Launch of GLYDO(TM) (Lidocaine HCI Jelly USP, 2%) GlobeNewswire
23-Sep-14 04:05PMSagent Pharmaceuticals Announces the Introduction of Oxaliplatin Injection, USP GlobeNewswire
17-Sep-14 04:30PMSagent Pharmaceuticals Announces the Launch of Ketorolac Tromethamine Injection, USP GlobeNewswire
05-Sep-14 01:21PMSagent Pharmaceuticals Announces the Launch of Ibandronate Sodium Injection GlobeNewswire
12-Aug-14 01:04PMSAGENT PHARMACEUTICALS, INC. Financials EDGAR Online Financials
05-Aug-14 05:01PMSAGENT PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Sagent Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, sources, manufactures, and markets pharmaceutical products, principally injectable-based generic equivalents to branded products in the United States. The company offers anti-infective products, such as Cefepime, an antibiotic used to treat infections of the urinary tract, and skin and skin structures, as well as moderate to severe pneumonia, intra-abdominal infections, and as empiric therapy for febrile neutropenic patients; and Levofloxacin, a fluoroquinolone antibacterial for the treatment of infections caused by susceptible bacteria, including nosocomial and community acquired pneumonia, sinusitis, chronic bronchitis, skin and skin structure infections, prostatitis, urinary tract infection, and pyelonephritis in adults of age 18 years or older. It also provides oncology products consisting of Docetaxel, an antineoplastic agent used to treat advanced or metastatic breast cancer after chemotherapy failure; Leucovorin Calcium, a folic acid derivative used to prevent harmful effects of methotrexate when methotrexate is used to treat certain types of cancer; and Zoledronic Acid, a bisphosphonate given intravenously to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer, as well as for treating osteoporosis. In addition, the company offers critical care products comprising Heparin, an anticoagulant used to prevent and treat blood clotting during and after surgery and dialysis. As of December 31, 2013, its product portfolio included 53 marketed products. It sells its products to hospitals, integrated delivery networks, and alternative site facilities through pharmaceutical wholesalers and specialty distributors. The company was formerly known as Sagent Holding Co. and changed its name to Sagent Pharmaceuticals, Inc. in April 2011. Sagent Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Schaumburg, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FLANAGAN ROBERT JDirectorSep 25Sale29.728,000237,760457,770Sep 25 08:34 PM
FLANAGAN ROBERT JDirectorSep 24Sale30.308,000242,400465,770Sep 25 08:34 PM
FLANAGAN ROBERT JDirectorSep 12Sale28.258,000226,000473,770Sep 12 06:32 PM
FLANAGAN ROBERT JDirectorSep 11Sale28.358,000226,800481,770Sep 12 06:32 PM
FLANAGAN ROBERT JDirectorAug 28Sale27.078,000216,560489,770Aug 29 06:03 PM
CompanyTechTarget, Inc.
IndustryInternet Information Providers
Market Cap294.72MEPS (ttm)0.06
P/E148.67EPS this Y-150.00%
Forward P/E22.70EPS next Y61.73%
PEG5.95EPS past 5Y-26.60%
P/S3.10EPS next 5Y25.00%
P/B1.80EPS Q/Q300.00%
Dividend-Sales Q/Q13.00%
Insider Own18.80%Inst Own58.10%
Insider Trans-31.66%Inst Trans-0.25%
Short Float1.90%EarningsNov 05/a
Analyst Recom1.70Target Price12.17
Avg Volume102.18K52W Range4.82 - 9.11
27-Aug-14 02:17PMTechTargets SearchServerVirtualization.com Announces Best of VMworld 2014 Award Winners Business Wire
15-Aug-14 01:04PMTECHTARGET INC Financials EDGAR Online Financials
08-Aug-14 02:28PMTECHTARGET INC Files SEC form 10-Q, Quarterly Report EDGAR Online
05-Aug-14 04:02PMTECHTARGET INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements EDGAR Online
05-Aug-14 04:01PMTechTarget Reports Second Quarter 2014 Financial Results Business Wire
05-Aug-14 07:07AMQ2 2014 TechTarget, Inc. Earnings Release - After Market Close CCBN
29-Jul-14 11:17AMTechTarget Awarded 7 National Online Editorial Awards by the American Society of Business Publication Editors (ASBPE) Business Wire
15-Jul-14 02:17PMTechTarget Website Redesign Drives Increases in Audience Engagement and Technology Project Insight Business Wire
08-Jul-14 02:17PMTechTarget to Release 2014 Second Quarter Financial Results on August 5, 2014 Business Wire
01-Jul-14 02:17PMTechTarget: Analysts $11/$12 Price Targets Are Below My Target Of $24 at Seeking Alpha
TechTarget, Inc. provides specialized online content and brand advertising that brings together buyers and sellers of corporate information technology (IT) products. It sells customized marketing programs, which enable IT vendors to reach corporate IT decision makers who are researching specific IT purchases, as well as provides conferences, seminars, and other in-person events through its Websites. The company also operates an integrated content platform that consists of a network of approximately 150 Websites that focus on media groups, including security, networking, storage, data center and virtualization technologies, chief information officer/IT strategy, business applications and analytics, application architecture and development, channels, and Internet content sites. In addition, it enables registered members to conduct their pre-purchase research by accessing vendor content, such as white papers, Webcasts, videocasts, virtual events, and podcasts across its network of Websites. The company's solutions facilitate the ability of IT professionals to find specific information related to their purchase decisions; and enable IT vendors to reach IT buyers that are researching specific solutions related to vendors' products and services. TechTarget, Inc. was founded in 1999 and is headquartered in Newton, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cotoia MichaelChief Operating OfficerAug 27Sale8.6112,000103,320156,757Aug 28 09:33 AM
Strakosch GregChief Executive OfficerAug 11Option Exercise5.0439,682199,9971,820,128Aug 12 10:25 AM
Hawk DonExecutive DirectorJul 23Sale8.235004,115114,953Jul 28 10:17 AM
Hawk DonExecutive DirectorJul 22Sale7.9821,600172,368115,453Jul 28 10:17 AM
Hawk DonExecutive DirectorJul 21Sale8.0110,00080,100137,053Jul 22 12:21 PM
CompanyBioSpecifics Technologies Corp.
Market Cap228.10MEPS (ttm)0.61
P/E57.70EPS this Y76.70%
Forward P/E14.46EPS next Y266.17%
PEG2.62EPS past 5Y6.70%
P/S18.10EPS next 5Y22.00%
P/B9.26EPS Q/Q-46.70%
Dividend-Sales Q/Q-18.20%
Insider Own4.30%Inst Own47.10%
Insider Trans-31.65%Inst Trans6.68%
Short Float2.22%EarningsAug 07
Analyst Recom2.00Target Price46.50
Avg Volume31.17K52W Range17.57 - 35.37
19-Sep-14 10:19AMBIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
19-Sep-14 08:30AMBioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference PR Newswire
18-Sep-14 04:17PMBioSpecifics Technologies Corp. Announces New MULTICORD and Retreatment Data for XIAFLEX® for Dupuytren's Contracture Presented at American Society for Surgery of the Hand Annual Meeting PR Newswire
11-Sep-14 08:26AMBIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
02-Sep-14 08:00AMBioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences PR Newswire
27-Aug-14 09:15AMBIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
22-Aug-14 06:00AMBIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
21-Aug-14 05:36PMBioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite PR Newswire
19-Aug-14 01:04PMBIOSPECIFICS TECHNOLOGIES CORP Financials EDGAR Online Financials
11-Aug-14 04:13PMBIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Changes in Registra EDGAR Online
BioSpecifics Technologies Corp., a biopharmaceutical company, is engaged in the development of an injectable collagenase for various indications primarily in the United States. It provides injectable collagenase under the XIAFLEX name for the treatment of Dupuytren's contracture and Peyronie's disease. The company also develops XIAFLEX injectable collagenase for frozen shoulder, cellulite, human lipoma, canine lipoma, and uterine fibroid indications, as well as for keloids, hypertrophic scars, scarred tendons, glaucoma, herniated intervertebral discs, and as an adjunct to vitrectomy indications. It has a development and license agreement with Auxilium Pharmaceuticals, Inc. The company was founded in 1957 and is headquartered in Lynbrook, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vogel Jeffrey Kenneth5% OwnerAug 18Sale29.352,00058,700534,730Aug 22 11:33 AM
Vogel Jeffrey Kenneth5% OwnerAug 14Sale28.857,961229,675536,730Aug 22 11:33 AM
Vogel Jeffrey Kenneth5% OwnerAug 13Sale28.852,03958,825541,906Aug 22 11:33 AM
Vogel Jeffrey Kenneth5% OwnerAug 12Sale28.8518,117522,675543,945Aug 22 11:33 AM
Vogel Jeffrey Kenneth5% OwnerAug 07Sale26.851,50040,275562,062Aug 22 11:33 AM
TickerHRL [NYSE, S&P 500]
CompanyHormel Foods Corporation
IndustryMeat Products
Market Cap13.45BEPS (ttm)2.18
P/E23.42EPS this Y4.80%
Forward P/E19.80EPS next Y15.70%
PEG2.13EPS past 5Y13.40%
P/S1.48EPS next 5Y11.00%
P/B3.77EPS Q/Q21.40%
Dividend1.57%Sales Q/Q5.80%
Insider Own0.30%Inst Own32.50%
Insider Trans18.08%Inst Trans-1.77%
Short Float2.05%EarningsAug 21/b
Analyst Recom2.30Target Price53.57
Avg Volume679.17K52W Range40.88 - 51.56
02-Oct-14 10:43AMEarly Glance: Food companies AP
01-Oct-14 06:20PMFinal Glance: Food companies AP
01-Oct-14 06:00PMToday's Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
01-Oct-14 01:16PMMidday Glance: Food companies AP
30-Sep-14 06:09PMToday's Market Thorns, Roses, and All Time Highs... Plus Quarter End.. Yahoo Finance Blogs
30-Sep-14 04:36PMIndexes Close Lower As Auto Parts Makers Skid at Investor's Business Daily
24-Sep-14 08:00AMHormel Foods Announces Advancements Business Wire
22-Sep-14 04:30PMHormel Foods Corporation Declares Quarterly Dividend Business Wire
22-Sep-14 07:00AMSKIPPY® Peanut Butter Launches SKIPPY® Yippee Marketing Campaign PR Newswire
19-Sep-14 02:39PMGatorade Says Goodbye to Derek Jeter at BusinessWeek
Hormel Foods Corporation processes, markets, and sells consumer-branded meat and food products. The company operates in five segments: Grocery Products, Refrigerated Foods, Jennie-O Turkey Store, Specialty Foods, and International & Other. The Grocery Products segment offers shelf-stable food products, including canned luncheon meats, shelf-stable microwaveable meals, stews, chilies, hash, meat spreads, flour and corn tortillas, salsas, and tortilla chips in the retail market. The Refrigerated Foods segment provides branded and unbranded pork and beef products for retail, foodservice, and fresh product customers. The Jennie-O Turkey Store segment offers branded and unbranded turkey products for retail, foodservice, and fresh product customers. The Specialty Foods segment is involved in the packaging and sale of various sugar and sugar substitute products, salt and pepper products, liquid portion products, dessert mixes, ready-to-drink products, sports nutrition products, gelatin products, and private label canned meats to retail and foodservice customers. This segment also processes, markets, and sells nutritional food products and supplements to hospitals, nursing homes, and other marketers of nutritional products. The International and Other segment manufactures, markets, and sells its products internationally. Hormel Foods Corporation sells its products through sales personnel, as well as through independent brokers and distributors primarily in the United States, Australia, Canada, China, England, Japan, Mexico, Micronesia, the Philippines, and South Korea. The company was formerly known as George A. Hormel & Company and changed its name to Hormel Foods Corporation in January 1995. Hormel Foods Corporation was founded in 1891 and is based in Austin, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAY THOMAS RGroup Vice PresidentSep 04Option Exercise19.3616,000309,68018,324Sep 08 05:12 PM
Murano Elsa ADirectorSep 04Sale50.9597849,83233,341Sep 09 05:52 PM
DAY THOMAS RGroup Vice PresidentSep 04Sale51.0012,000611,94711,432Sep 08 05:12 PM
Kremin Donald HGroup Vice PresidentSep 03Sale51.121,20061,34613,754Sep 04 04:19 PM
Brady Deanna TGroup Vice PresidentAug 28Option Exercise19.1324,000459,00041,077Aug 29 10:32 AM
1 2 next